We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

GLOBAL Clinical Study (GLOBAL)

This study is ongoing, but not recruiting participants.
ClinicalTrials.gov Identifier:
First Posted: November 30, 2012
Last Update Posted: February 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Global Genomics Group, LLC

The GLOBAL study is an international multi-center, prospective study designed to enroll up to 10,000 consecutive eligible subjects who are clinically referred for coronary CT angiography for assessment of suspected coronary artery disease (CAD).

The purpose of the study is to perform extensive biomarker analysis of atherosclerosis in patients phenotyped using advanced imaging modalities of atherosclerosis.

Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genetic Loci and the Burden of Atherosclerotic Lesions

Resource links provided by NLM:

Further study details as provided by Global Genomics Group, LLC:

Primary Outcome Measures:
  • Genome-Wide Association [ Time Frame: Baseline ]
    The primary analysis will be a genome-wide association analysis, to determine candidate genes and markers underlying coronary artery disease.

Biospecimen Retention:   Samples With DNA
Whole blood, serum, plasma, buffy coat and RNA PAXgene

Estimated Enrollment: 10000
Study Start Date: December 2012
Estimated Study Completion Date: December 2016
Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Subjects with CAD
Subjects without CAD


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients presenting for clinically indicated coronary CT angiography for an assessment of possible CAD are potential study candidates.

Inclusion Criteria:

  1. Ages 18-90
  2. Caucasian and of Non-Hispanic or Non-Latino origin
  3. Referral for coronary CT angiography to evaluate for presence of CAD
  4. The patient has signed the appropriate Institutional Review Board approved Informed Consent Form

Exclusion Criteria:

  1. Immunosuppressive or immunomodulatory therapy including any dose of systemic corticosteroids in the preceding 30 days (except if steroids are administered as pre-medication prior to contrast administration for CT scan within 24 hours).
  2. Chemotherapy in the preceding year
  3. Major surgery in the preceding 2 months
  4. Blood or blood product transfusion in the preceding 2 months
  5. Subjects for whom coronary CT angiography is contraindicated per institutional standard of care
  6. Subjects with previous coronary arterial revascularization (PCI or CABG)
  7. Subjects with atrial fibrillation/flutter or frequent irregular or rapid heart rhythms, which occurred within the past 3 months
  8. Subjects with a pacemaker or implantable cardioverter-defibrillator implant
  9. Active congestive heart failure or the presence of known non-ischemic cardiomyopathy
  10. Known genetic disorders of atherosclerosis, lipid or lipoprotein metabolism
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01738828

  Show 48 Study Locations
Sponsors and Collaborators
Global Genomics Group, LLC
Study Director: Szilard Voros, MD Global Genomics Group, LLC
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Global Genomics Group, LLC
ClinicalTrials.gov Identifier: NCT01738828     History of Changes
Other Study ID Numbers: CR0001
First Submitted: November 28, 2012
First Posted: November 30, 2012
Last Update Posted: February 9, 2016
Last Verified: February 2016

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases